Back to Search
MOHAMMAD PASHA, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1720030554IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
038915(CT)
Pain Medicine (Physical Medicine & Rehabilitation) Physician
Physical Medicine & Rehabilitation — Pain Medicine
Code: 2081P2900X
038915(CT)
Diagnostic Radiology Physician
Radiology — Diagnostic Radiology
Code: 2085R0202X
038915(CT)
Education
OTHER
Class of 1984
Research & Publications (20)
Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins.
PMID 11927778·J Biosci·2002
8-other
Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2]YFa-on antinociception and opioid receptor regulation.
PMID 19560378·Eur J Pain·2010
7-preclinical
Effect of 3-thienylalanine-ornithine-proline, new sulfur-containing angiotensin-converting enzyme inhibitor on blood pressure and oxidative stress in spontaneously hypertensive rats.
PMID 19188834·J Cardiovasc Pharmacol·2009
7-preclinical
Detection of chronic obstructive pulmonary disease using spirometric screening.
PMID 19377418·Mymensingh Med J·2009
8-other
Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension.
PMID 18475146·J Hypertens·2008
8-other
Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension.
PMID 18325347·Free Radic Biol Med·2008
8-other
The genetic aspects of pre-eclampsia: achievements and limitations.
PMID 18437552·Biochem Genet·2008
6-review
Derivatization of guar to sodium carboxy methyl hydroxy propyl derivative; characterization and evaluation.
PMID 18166518·Pak J Pharm Sci·2008
8-other
YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment.
PMID 18183621·J Neurosci Res·2008
7-preclinical
Molecular iodine catalyzed synthesis of aryl-14H-dibenzo[a, j]xanthenes under solvent-free condition.
PMID 17157011·Bioorg Med Chem Lett·2007
8-other
cDNA cloning, gene organization and variant specific expression of HIF-1 alpha in high altitude yak (Bos grunniens).
PMID 17045424·Gene·2007
4-observational
In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
PMID 17473456·Biol Pharm Bull·2007
7-preclinical
Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
PMID 17442289·Clin Chim Acta·2007
8-other
Expression and functional activity of pro-oxidants and antioxidants in murine heart exposed to acute hypobaric hypoxia.
PMID 17825300·FEBS Lett·2007
7-preclinical
Endothelial nitric oxide synthase gene variants contribute to oxidative stress in COPD.
PMID 17658478·Biochem Biophys Res Commun·2007
8-other
Ultrasound assisted synthesis of delta-chloroesters from tetrahydrofuran and acyl chlorides in the presence of catalytic zinc dust.
PMID 16293525·Ultrason Sonochem·2006
8-other
A comparative study and development of an improved method for the reduction of nitroarenes into arylamines by Al/NH4X (X=Cl, Br, I) in methanol under ultrasonic conditions.
PMID 16223686·Ultrason Sonochem·2006
4-observational
Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema.
PMID 17099031·Chest·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 82 NEW PARK AVE
NORTH FRANKLIN, CT 06254 - Phone
- (860) 889-7345
Quick Facts
- NPI
- 1720030554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile